Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 10/20 | 0.58 |
| ▸ | ABCC9 | O60706 | 4/20 | 0.57 |
| ▸ | KCNE1 | P15382 | 3/20 | 0.56 |
| ▸ | KCNQ1 | P51787 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.56 |
| ▸ | ABCC8 | Q09428 | 2/20 | 0.54 |
| ▸ | KCNJ11 | Q14654 | 2/20 | 0.54 |
| ▸ | KCNJ8 | Q15842 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL481521 | 1.00 | KDM4E (0.60) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL9260381 | 1.00 | KDM4E (0.60) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL8616133 | 1.00 | KDM4E (0.60) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL9260385 | 1.00 | KDM4E (0.60) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL8342199 | 1.00 | KDM4E (0.60) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL8983412 | 1.00 | KDM4E (0.60) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| Hydrochloric Acid SCHEMBL9851469 | 0.99 | KDM4E (0.58) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL9315796 | 0.85 | KDM4E (0.47) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL9395036 | 0.85 | KDM4E (0.44) | KDM4EABCB1ABCC9KCNE1KCNQ1 | |
| SCHEMBL9394349 | 0.85 | KDM4E (0.44) | KDM4EABCB1ABCC9KCNE1KCNQ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5239090-A | Certain optically active 3,4-dihydrobenzopyran-4-ols which are intermediates | BEECHAM GROUP P.L.C. (GB) | 1993-08-24 | — | — | US | claimed |
| EP-0385584-A1 | Method for the preparation of 4-(cyclic-amido)-2H-1-benzopyrans and 4-amino-3-hydroxy-2H-1-benzopyrans | BEECHAM GROUP PLC (GB) | 1990-09-05 | — | — | EP | claimed |
| EP-0076075-B1 | PHARMACEUTICALLY ACTIVE BENZOPYRAN COMPOUNDS | BEECHAM GROUP PLC (GB) | 1986-11-20 | — | — | EP | claimed |
| JP-3014573-A | — | — | None | — | — | JP | disclosed |
| EP-1937669-B9 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA NV (BE) | 2012-07-18 | — | — | EP | disclosed |
| EP-1937669-B1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA NV (BE) | 2012-02-01 | — | — | EP | disclosed |
| US-7838553-B2 | Benzopyran derivatives as potassium channel openers | JANSSEN PHARMACEUTICA NV (BE) | 2010-11-23 | — | — | US | disclosed |
| US-7812183-B2 | Benzopyran derivatives as potassium channel openers | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-12 | — | — | US | disclosed |
| EP-1940516-A2 | BENZOPYRAN AND PYRANOPYRIDINE DERIVATIVES AS POTASSIUM CHANNEL OPENERS | Janssen Pharmaceutica, N.V. (BE) | 2008-07-09 | — | — | EP | disclosed |
| EP-1937669-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-07-02 | — | — | EP | disclosed |
| US-20070072832-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-29 | — | — | US | disclosed |
| US-4575511-A | Anti-hypertensive chromanol derivatives | BEECHAM GROUP P.L.C. (GB) | 1986-03-11 | — | — | US | disclosed |
| US-4571406-A | Anti-hypertensive chromans and chromenes | BEECHAM GROUP P.L.C. (GB) | 1986-02-18 | — | — | US | disclosed |
| US-4510152-A | Antihypertensive chromenes and chromans | BEECHAM GROUP P.L.C. (GB) | 1985-04-09 | — | — | US | disclosed |
| EP-0126367-A1 | Chroman and chromene derivatives | BEECHAM GROUP PLC (GB) | 1984-11-28 | — | — | EP | disclosed |
| EP-0126311-A2 | Benzopyran derivatives. | BEECHAM GROUP PLC (GB) | 1984-11-28 | — | — | EP | disclosed |
| EP-0126350-A1 | Novel compounds | BEECHAM GROUP PLC (GB) | 1984-11-28 | — | — | EP | disclosed |
| EP-0120427-A1 | 3,4-Dihydro-thiaoxo-1-pyrrolidinyl-or piperidinyl-ZH-benzo[b]pyrons | BEECHAM GROUP PLC (GB) | 1984-10-03 | — | — | EP | disclosed |
| US-4446113-A | HYPOTENSIVE AGENTS | BEECHAM GROUP P.L.C. (GB) | 1984-05-01 | — | — | US | disclosed |
| EP-0093535-A1 | Novel chromenes and chromans | BEECHAM GROUP PLC (GB) | 1983-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072832-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | KCNJ2, KCNN1, KCNN3 | KDM4E 885/4885ABCB1 158/4885ABCC9 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.